3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 1/2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
16
Neoplasm Metastasis
3
Urologic Diseases
1
Salivary Gland Neoplasms
1
Recurrence
1
Radiation Injuries
1
Prostate Cancer Metastatic
1
Oligorecurrent and Oligoprogressive Prostate Cancer Patients
1
Neoplasms
1
Neoplasm Recurrence, Local
1
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
1
Intraprostatic Prostate Cancer
1
Gastrointestinal Diseases
1
Interventions
Radiotherapy, Intensity-Modulated
3
Diet Therapy
3
Blood Specimen Collection
3
Radiotherapy
2
Radiosurgery
2
Radiation Dose Hypofractionation
2
Brachytherapy
2
endostar protein
1
Xylitol
1
Surgical Procedures, Operative
1
Sildenafil Citrate
1
Serotonin Plasma Membrane Transport Proteins
1
Saline Solution
1
S 1 (combination)
1
Proton Therapy
1
Probiotics
1
Oral Hygiene
1
Mental Status and Dementia Tests
1
Menogaril
1
Magnetic Resonance Spectroscopy
1
Lymph Node Excision
1
Low-Level Light Therapy
1
Immunotherapy
1
Hyperbaric Oxygenation
1
Heart Rate
1
Fatty Acids, Omega-3
1
Electroacupuncture
1
Early Intervention, Educational
1
Dexamethasone
1
Centella asiatica extract
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Radiation Injuries
×
Androgen Antagonists
×
Clear all
NCT07483658
2026-03-19
HYP-OP-RT
CHU de Quebec-Universite Laval
Phase NA
Not yet recruiting
434 enrolled